# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-13-001911
Filing Date
2013-04-17
Accepted
2013-04-17 17:14:36
Documents
21
Period of Report
2013-04-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k041113_actinium.htm | 8-K | 28141
2 | DELAWARE CERTIFICATE OF INCORPORATION FOR ACTINIUM PHARMACEUTICALS, INC. | f8k041113ex3i_actinium.htm | EX-3.1 | 2757
3 | BYLAWS FOR ACTINIUM PHARMACEUTICALS, INC. | f8k041113ex3ii_actinium.htm | EX-3.2 | 98242
4 | DELAWARE CERTIFICATE OF MERGER | f8k041113ex3iii_actinium.htm | EX-3.3 | 836
5 | NEVADA ARTICLES OF MERGER | f8k041113ex3iv_actinium.htm | EX-3.4 | 8922
6 | PRESS RELEASE DATED APRIL 17, 2013 | f8k041113ex99i_actinium.htm | EX-99.1 | 18218
7 |  | ex99i.jpg | GRAPHIC | 18735
8 |  | ex3iii.jpg | GRAPHIC | 109662
9 |  | ex3iv_1.jpg | GRAPHIC | 79988
10 |  | ex3iv_2.jpg | GRAPHIC | 72576
11 |  | ex3iv_3.jpg | GRAPHIC | 56383
12 |  | ex3iv_4.jpg | GRAPHIC | 55401
13 |  | ex3iv_5.jpg | GRAPHIC | 69815
14 |  | ex3iv_6.jpg | GRAPHIC | 86036
15 |  | ex3iv_7.jpg | GRAPHIC | 103862
16 |  | ex3iv_8.jpg | GRAPHIC | 123466
17 |  | ex3iv_9.jpg | GRAPHIC | 130123
18 |  | ex3iv_10.jpg | GRAPHIC | 97437
19 |  | ex3i_1.jpg | GRAPHIC | 129913
20 |  | ex3i_2.jpg | GRAPHIC | 132379
21 |  | ex3i_3.jpg | GRAPHIC | 32281
| Complete submission text file | 0001213900-13-001911.txt |  | 1948518

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 13767544
SIC: 6770 Blank Checks